Renal replacement therapy in acute kidney injury: controversy and consensus
Claudio Ronco, Zaccaria Ricci, Daniel De Backer, John A Kellum, Fabio S Taccone, Michael Joannidis, Peter Pickkers, Vincenzo Cantaluppi, Franco Turani, Patrick Saudan, Rinaldo Bellomo, Olivier Joannes-Boyau, Massimo Antonelli, Didier Payen, John R Prowle, Jean-Louis Vincent
Critical Care (UK) | BMC | Published : 2015
Renal replacement therapies (RRTs) represent a cornerstone in the management of severe acute kidney injury. This area of intensive care and nephrology has undergone significant improvement and evolution in recent years. Continuous RRTs have been a major focus of new technological and treatment strategies. RRT is being used increasingly in the intensive care unit, not only for renal indications but also for other organ-supportive strategies. Several aspects related to RRT are now well established, but others remain controversial. In this review, we review the available RRT modalities, covering technical and clinical aspects. We discuss several controversial issues, provide some practical reco..View full abstract
DDB is a member of the Baxter-Gambro European Medical Advisory Board. JAK has received research funding and consulting fees from Gambro (a brand of Baxter, Deerfield, IL, USA) and Fresenius (Bad Homburg, Germany). MJ has received speaker or consulting fees from Frenenius and Gambro. FT has received honoraria from Bellco (North Amityville, NY, USA) for lectures. The other authors declare that they have no competing interests.